Skip to content

AHC International Media Library

Alternating Hemplegia of Childhood and ATP1A3 disorders

  • Interviews
  • Home Videos
  • News
  • Associations
  • Documentaries
  • Presentations
  • Contact
  • About AHCIM
  • Articles
  • Toggle search form

Arn M.J.M. van den Maagdenberg at the ATP1A3 symposium in disease – Chicago 2018

Posted on November 30, 2018November 30, 2018 By siggi

Professor Arn M.J.M van den Maagdenberg talks about why some AHC patients have a mutation in ATP1A3 and some in ATP1A2?
What is the sodium/potassium pump?
If AHC patients do not have a mutation in AHC1A3 or 2 what other gene is affected? Do they have another disorder?

Arn M.J.M. van den Maagdenberg is professor of molecular and functional neurogenetics at the departments of Human Genetics and Neurology of the Leiden University Medical Centre (LUMC).
In addition, he is vice-chair of the medicine education committee and chair of the advisory board of the LUMC Medical Research Profile ‘Translational Neuroscience’.
He is also member of the advisory boards of the Dutch Epilepsy Fund, the ‘American Registry for Migraine Research’ (ARMR), and the world-wide ‘Global Migraine Registry’ (GMR) initiative.

Interviews Tags:arn m.j.m. van den maagdenberg, atp1a2, atp1a3, atp1a3 chicago, atp1a3 reykjavik, professor, sodium pump

Post navigation

Previous Post: Alfred George at the ATP1A3 symposium in disease, Chicago 2018
Next Post: Dr. Kevin Ess talks about past and future research at the ATP1A3 symposium in Chicago 2018

Related Posts

Willem Zorge – London 2016 Interviews
Arsen Hunanyan – Duke University 2014 Interviews
Dominique Poncelin Interviews
Rick Simpson – Would cbd oil help AHC? Interviews
Vicky Lewis and Adrian Kowal – London 2016 Interviews
Aaron Talsma – Research assistant at University of Pittsburgh Interviews

Copyright © 2026 AHC International Media Library.

Powered by PressBook Masonry Dark